Additionally, TAMs from tumor-bearing CCR2 knockout mice expressed a reduced amount of Vegf, and the tumor vasculature was less leaky and more mature, underlining the importance of CCR2 signaling in GBM angiogenesis [48]. The gene discussed is CCR2; the disease is glioblastoma.